Cytokine interference in infection

National Institutes of Health
Owner:National Institutes of Health

Webinar URL:

Webinar Details

Dr. O’Garra’s laboratory studies cells and molecules that control our immune systems to understand how they respond to infections and influence the outcomes and what goes wrong when infections damage healthy cells. For example, some infected individuals are protected while others go on to progress to disease such as tuberculosis (TB), which is caused by infection with Mycobacterium tuberculosis (M. tuberculosis). TB is a major cause of morbidity and mortality worldwide and efforts to control this disease are hampered by difficulties with diagnosis, prevention, and treatment. Most people infected with M. tuberculosis remain asymptomatic or have latent (noninfectious) TB, but they have a 10 percent lifetime risk of developing the active form of the disease. In 2010, Dr. O’Garra’s laboratory identified a gene signature dominated by type I interferon (IFN) inducible genes in the bloodstream of people with TB, which disappears during successful treatment. The lab is also studying the regulation and function of type I IFNs which exacerbate bacterial infections, in part, by inducing a regulatory cytokine called IL-10. Type I IFNs are cytokines that have been shown for years to be important in the control of viral infections. In experimental models, the lab showed that elevated levels of this cytokine lead to increased TB disease; subsequent studies now provide further knowledge regarding the heterogeneity of this blood signature in some, but not all, asymptomatic TB contacts and how this signature relates to whether they are protected or will develop the disease. During the lecture, Dr. O’Garra will discuss several potential mechanisms underlying the contribution of type I IFN to the development of TB and diseases caused by other bacterial infections. She will also discuss the impairment of protective responses.

SpeakerAnne O'Garra
Anne O'Garra
She received her bachelor's degree in microbiology and biochemistry at the University of London. At the NIMR, she earned her Ph.D. in microbiology, staying on there for a four-year post-doctorate in immunology. In 1987, O'Garra left England for Palo Alto, California, to work for the DNAX Research Institute, where by 2000 she had become a principal staff scientist in the department of immunobiology.[5] In 2001, O'Garra became the Head of the Division of Immunoregulation at the MRC National Institute for Medical Research (NIMR) in London.[6] Since 2015, she is Associate Research Director at the Francis Crick Institute, the successor institute to the NIMR.


Eastern Time (US and Canada)

June 12, 2019 3:00 pm GMT-04:00

Beijing, Shanghai (China)

June 13, 2019 3:00 am GMT+08:00

Berlin (Germany)

June 12, 2019 9:00 pm GMT+02:00


Med. 30-60 min



Related Subjects

Webinar Type